[Leukemic stem cell targeting therapy].
Chen
Yun-Xian
YX
cyx1228@21cn.com
Zhong
Xue-Yun
XY
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002867:Chromones / Q000494:pharmacology / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007938:Leukemia / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D007976:Leupeptins / Q000494:pharmacology / Q000627:therapeutic use; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use; D016328:NF-kappa B / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D000081082:Phosphoinositide-3 Kinase Inhibitors
D000970:Antineoplastic Agents; D002867:Chromones; D007976:Leupeptins; D009025:Morpholines; D016328:NF-kappa B; D000081082:Phosphoinositide-3 Kinase Inhibitors; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde